期刊文献+

普伐他汀对内皮祖细胞培养中扩增及黏附能力的影响 被引量:1

Effects of Pravastatin on expand and adhesion ability of endothelial progenitor cells
下载PDF
导出
摘要 目的:观察普伐他汀对内皮祖细胞(endothelial progenitor cells,EPCs)培养中扩增及黏附能力的影响。方法:采用密度梯度离心法分离人脐血单个核细胞,接种到包被有人纤维连接蛋白的培养皿,分为对照组(未加细胞因子)、V组(加VEGF10 ng/m1)、P0.1组(加普伐他汀0.1 μmol/L)、P0.01组(加普伐他汀0.01μmol/L),培养6d后,采用流式细胞术PE-CD34及FITC-VE-Cadherin双标法测定各组扩增细胞数, 采用黏附能力测定试验测定黏附能力。结果:V组、P0.1组、P0.01组的扩增EPCs数显著高于对照组(P< 0.01),且P0.1组、P0.01组均显著高于V组(P<0.001)。P0.1组、P0.01组的黏附EPCs数显著高于对照组(P<0.001)。结论:普伐他汀可显著提高培养EPCs的扩增能力及黏附能力。 Objective: To investigate the effects of Pravastatin on expand and adhesion ability of endothelial progenitor cells (EPCs). Methods: Mononuclear fraction of human umbilical cord blood was obtained by Ficoll density gradient centrifugation. Isolated ceils were plated on fibronectin coated culture dishes. Ceils were divided into four groups: group control, group Ⅴ, group PO.1, group P0.01(supplemented with none cytokine, VEGF10ng/ml, 0.1μmol/L Pravastatin, 0.01μmol/L Pravastatin. respectively), after six days in culture, fluorescenceactivated cell sorting analysis of PE-CD34 and FITC-VE-Cadherin was performed to detect the numbers of the expand of EPCs in each group, adhesion assay was performed by replating cells on fibronectin coated dishes, and then counting adherent cells. Results: Numbers of expand EPCs of group Ⅴ, group P0.1 and group P0.01 were significantly inceased as compared with those of group control(P〈0.01), and numbers of expand EPCs of group P0.1 and group P0.01 were more than those of group Ⅴ(P〈0.001).Numbers of adhesive EPCs of group P0.1 and group P0.01 were significantly inceased as compared with those of group control(P〈0.001). Conclusion: Pravastatin can significantly enhance the expand and adhesion ability of endothelial progenitor cells.
出处 《温州医学院学报》 CAS 2005年第4期265-267,共3页 Journal of Wenzhou Medical College
基金 浙江省自然科学基金资助项目(M303648)
关键词 他汀类药内皮祖细胞细胞培养 statins endothelial progenitor cells cell culture
  • 相关文献

参考文献12

  • 1陈君柱,张芙荣,朱建华,朱军慧,谢旭东,孙坚,尚云鹏,郭晓纲.他汀类药物对外周血内皮祖细胞数量和功能的影响[J].中华心血管病杂志,2004,32(4):346-350. 被引量:21
  • 2Arasaha T, masuda H ,Takahashi T, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science,1997, 275(5302): 964-967.
  • 3Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization[J]. Circ Res, 1999,85(3): 221-228.
  • 4Werner N, Junk S, Laufs U,et al.Intravenous Transfusion of Endothelial ProgenitorCells Reduces Neointima Formation After Vascular Injury[J]. Circ Res,2003,93(2) :e17-e24.
  • 5Maron DJ, Fazio S, Linton MF. Current perspectives on statins[J]. Circulation,2000, 101 (6):207-213.
  • 6Urbich C, Dernbach E, Zeiher AM,et al.Double-edged role of statins in angiogenesis signaling[J]. Circ Res, 2002(6), 90:737-744.
  • 7Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells[J]. Circulation, 2002,105(25): 3017- 3024.
  • 8张怀勤,胡盛寿,杨德业,张浩,周浩,黄晓燕,吴建波.脐血来源的人类内皮前体细胞培养的实验研究[J].中国循环杂志,2003,18(6):456-457. 被引量:16
  • 9Llevadot J, Murasawa S, Kureishi Y, et al. HMG-CoA reductase inhibitor mobilizes bone-marrow derived endothelial progenitor cells[J]. J Clin Invest,2001,108(3): 399-405.
  • 10Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J]. Circulation, 2001,103(24):2885-2890.

二级参考文献18

  • 1Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science, 1997, 275: 964-967.
  • 2Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000, 95: 952-958.
  • 3Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res, 1999, 85: 221-228.
  • 4Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med, 2001, 7: 430-436.
  • 5Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med, 2002, 8: 607-612.
  • 6Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerate reendothelialization. Circulation, 2002, 105:3017-3024.
  • 7Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med, 2003, 348:593-600.
  • 8Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res, 2001, 89: E1-7.
  • 9Maron DJ, Fazio S, Linton MF. Current perspectives on statins. Circulation, 2000, 101: 207-213.
  • 10Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA, 2000, 97: 3422-3427.

共引文献35

同被引文献25

  • 1袁红,陈君柱,王兴祥.高糖对外周血内皮祖细胞数量和功能的影响[J].解放军医学杂志,2004,29(9):803-806. 被引量:20
  • 2刘燕荣,陈君柱,王兴祥,朱军慧,谢旭东,孙坚.冠心病患者外周血内皮祖细胞的数量和功能变化[J].浙江大学学报(医学版),2005,34(2):163-166. 被引量:5
  • 3Asahara T,Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis [ J ]. Science, 1997,275:964 - 967.
  • 4Harraz M, Jiao C, Hanlon HD, et al. CD34- blood-derived human endothelial cells progenitors [ J ]. Stem Cells, 2001,19 : 304 - 312.
  • 5Hirashima M, Kataoka H, Nishikawa S, et al. Maturation of embryonic stem cells into endothelial cells in an vitro model of vasculogenesis [ J ]. Blood ,1999,93: 1253 - 1263.
  • 6Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells [ J ]. Blood, 1997,90: 5002 - 5012.
  • 7Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from A C133 - positive progenitor cells [ J ]. Blood,2000, 95:3106 -3112.
  • 8Cines D,Pollak E, Buck C, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders [ J ]. Blood, 1998, 91 : 3527 - 3561.
  • 9Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 ^+ cells identifies a population of functional endothelial precursors[ J ]. Blood ,2000,95: 952 - 958.
  • 10Takahashi T,Kalka C, Masuda H, et al. lschemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization [ J ]. Nat Med, 1999,5 : 434 - 438.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部